Medical Journals

A Novel, Conformation-specific Allosteric Inhibitor of the Tachykinin Nk2 Receptor (Nk2r) with Functionally Selective Properties.

Authors:
  • Maillet Emeline L
  • Pellegrini Nadia
  • Valant Celine
  • Bucher Bernard
  • Hibert Marcel
  • Bourguignon Jean-Jacques
  • Galzi Jean-Luc

From: Departement Recepteurs et Protéines Membranaires; ESBS, Illkirch, France. emeline.maillet@mssm.edu

The FASEB journal : official publication of the Federation of American Societies for Experimental Biology

  • Publish Date: Jul 2007
  • ISSN: 1530-6860
  • Volume: 21
  • Issue: 9
  • Pages: 2124-34
  • Medium: Internet
  • Language: English
  • Citation (JAMA): Maillet Emeline L, Pellegrini Nadia, Valant Celine, et al. A Novel, Conformation-specific Allosteric Inhibitor of the Tachykinin Nk2 Receptor (Nk2r) with Functionally Selective Properties.. FASEB J. Jul 2007;21:2124-34

Abstract

The orthosteric agonist neurokinin A (NKA) interacts with the tachykinin NK2 receptors (NK2Rs) via an apparent sequential binding process, which stabilizes the receptor in at least two different active conformations (A1L and A2L). The A1L conformation exhibits fast NKA dissociation kinetics and triggers intracellular calcium elevation; the A2L conformation exhibits slow NKA dissociation kinetics and triggers cAMP production. The new compound LPI805 is a partial and noncompetitive inhibitor of NKA binding to NK2Rs. Analysis of NKA dissociation in the presence of LPI805 suggests that LPI805 decreases the number of NKA-NK2R complexes in A2L conformation while increasing those in the A1L conformation. Analysis of signaling pathways of NK2Rs shows that LPI805 dramatically inhibits the NKA-induced cAMP response while slightly enhancing the NKA-induced calcium response. Analysis of NKA association kinetics reveals that LPI805 promotes strong and specific destabilization of the NKA-NK2R complexes in the A2L conformation whereas access of NKA to the A1L conformations is unchanged. Thus, to our knowledge, LPI805 is the first example of a conformation-specific allosteric antagonist of a G-protein-coupled receptor. This work establishes the use of allosteric modulators in order to promote functional selectivity on certain agonist-receptor interactions.

Mesh Headings (Keywords): Allosteric Regulation, Aminoacetonitrile, Animals, Calcium, Calcium Signaling, Cell Line, Cyclic AMP, Cyclic AMP-Dependent Protein Kinases, Fluorescence Resonance Energy Transfer, Fluorescent Dyes, Genes, Reporter, Humans, Kidney, Kinetics, Naphthalenes, Neurokinin A, Protein Binding, Protein Conformation, Rats, Receptors, Neurokinin-2, Recombinant Fusion Proteins, Second Messenger Systems, Structure-Activity Relationship, Substrate Specificity


Check for Full Text / PubMed Unique Identifier (PMID): 17371796


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.